Skip to main content
. 2026 Oct 8;15(19):7762. doi: 10.3390/jcm15197762
DFI Disease-free interval
ECOG Eastern Cooperative Oncology Group performance status
ENETS European Neuroendocrine Tumor Society
MDT Multidisciplinary tumor board
MEN Multiple endocrine neoplasia
NEC Neuroendocrine carcinoma
OS Overall survival
PRRT Peptide receptor radionuclide therapy
RFA Radiofrequency ablation
SIRT Selective internal radiation therapy
SSAs Somatostatin analogs
SSTR Somatostatin receptor
TAE Transarterial embolization
VHL Von Hippel–Lindau syndrome